{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:45:14Z","timestamp":1789469114510,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T00:00:00Z","timestamp":1284422400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s11910-010-0143-1","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T01:40:25Z","timestamp":1284342025000},"page":"448-458","source":"Crossref","is-referenced-by-count":11,"title":["Neuro-ophthalmologic Complications and Manifestations of Upper and Lower Motor Neuron Facial Paresis"],"prefix":"10.1007","volume":"10","author":[{"given":"M. Tariq","family":"Bhatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade S.","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastas F.","family":"Pass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa A.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,14]]},"reference":[{"issue":"12","key":"143_CR1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.56.12.1509","volume":"56","author":"CA Anderson","year":"1999","unstructured":"Anderson CA, Sandberg E, Filley CM, et al.: One and one-half syndrome with supranuclear facial weakness: magnetic resonance imaging localization. Arch Neurol 1999, 56(12):1509\u20131511.","journal-title":"Arch Neurol"},{"issue":"13","key":"143_CR2","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJMcp041120","volume":"351","author":"DH Gilden","year":"2004","unstructured":"Gilden DH: Clinical practice. Bell\u2019s palsy. N Engl J Med 2004, 351(13):1323\u20131331.","journal-title":"N Engl J Med"},{"issue":"2","key":"143_CR3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.survophthal.2006.12.009","volume":"52","author":"I Rahman","year":"2007","unstructured":"Rahman I, Sadiq SA: Ophthalmic management of facial nerve palsy: a review. Surv Ophthalmol 2007, 52(2):121\u2013144.","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"143_CR4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.otohns.2008.09.028","volume":"140","author":"A Razfar","year":"2009","unstructured":"Razfar A, Afifi AM, Manders EK, et al.: Ocular outcomes after gold weight placement and facial nerve resection. Otolaryngol Head Neck Surg 2009, 140(1):82\u201385.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"143_CR5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0030-6665(20)30967-1","volume":"25","author":"WY Hoffman","year":"1992","unstructured":"Hoffman WY: Reanimation of the paralyzed face. Otolaryngol Clin North Am 1992, 25(3):649\u2013667.","journal-title":"Otolaryngol Clin North Am"},{"key":"143_CR6","first-page":"551","volume-title":"The Facial Nerve","author":"J Conley","year":"2000","unstructured":"Conley J, May M: Perspectives in facial reanimation. In The Facial Nerve. edn 2. Edited by May M, Schaitkin BM. New York: Thieme Medical Publishers; 2000:551\u2013570.","edition":"2"},{"issue":"11","key":"143_CR7","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00405-008-0788-4","volume":"265","author":"RC Graaf van de","year":"2008","unstructured":"van de Graaf RC, IJpma FF: Remarks on the early history of Bell\u2019s palsy. Eur Arch Otorhinolaryngol 2008, 265(11):1433\u20131434.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"11","key":"143_CR8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1699-0463.1997.tb05089.x","volume":"105","author":"J Schirm","year":"1997","unstructured":"Schirm J, Mulkens PS: Bell\u2019s palsy and herpes simplex virus. APMIS 1997, 105(11):815\u2013823.","journal-title":"APMIS"},{"issue":"1","key":"143_CR9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2273.1990.tb00427.x","volume":"15","author":"PP Devriese","year":"1990","unstructured":"Devriese PP, Schumacher T, Scheide A, et al.: Incidence, prognosis and recovery of Bell\u2019s palsy. A survey of about 1,000 patients (1974\u20131983). Clin Otolaryngol Allied Sci 1990, 15(1):15\u201327.","journal-title":"Clin Otolaryngol Allied Sci"},{"issue":"4","key":"143_CR10","first-page":"258","volume":"46","author":"WA Hauser","year":"1971","unstructured":"Hauser WA, Karnes WE, Annis J, Kurland LT: Incidence and prognosis of Bell\u2019s palsy in the population of Rochester, Minnesota. Mayo Clin Proc 1971, 46(4):258\u2013264.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"143_CR11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/lary.1978.88.5.787","volume":"88","author":"KK Adour","year":"1978","unstructured":"Adour KK, Byl FM, Hilsinger RL Jr, et al: The true nature of Bell\u2019s palsy: analysis of 1,000 consecutive patients. Laryngoscope 1978, 88(5):787\u2013801.","journal-title":"Laryngoscope"},{"issue":"6","key":"143_CR12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archotol.1984.00800320028006","volume":"110","author":"N Yanagihara","year":"1984","unstructured":"Yanagihara N, Mori H, Kozawa T, et al.: Bell\u2019s palsy. Nonrecurrent v recurrent and unilateral v bilateral. Arch Otolaryngol 1984, 110(6):374\u2013377.","journal-title":"Arch Otolaryngol"},{"issue":"11","key":"143_CR13","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1474-4422(08)70222-9","volume":"7","author":"D Gilden","year":"2008","unstructured":"Gilden D: Treatment of Bell\u2019s palsy\u2014the pendulum has swung back to steroids alone. Lancet Neurol 2008, 7(11):976\u2013977.","journal-title":"Lancet Neurol"},{"issue":"2","key":"143_CR14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/019459988509300202","volume":"93","author":"JW House","year":"1985","unstructured":"House JW, Brackmann DE: Facial nerve grading system. Otolaryngol Head Neck Surg 1985, 93(2):146\u2013147.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"143_CR15","first-page":"275","volume-title":"The Facial Nerve","author":"BM Schaitkin","year":"2000","unstructured":"Schaitkin BM, May M: Reporting recovery of facial function. In The Facial Nerve. edn 2. Edited by May M, Schaitkin BM. New York: Thieme Medical Publishers; 2000:275\u2013294.","edition":"2"},{"issue":"26","key":"143_CR16","first-page":"1454","volume":"149","author":"JA Ru de","year":"2005","unstructured":"de Ru JA, van Benthem PP, Hordijk GJ: Arguments favouring the pharmacotherapy of Bells\u2019 palsy [in Dutch]. Ned Tijdschr Geneeskd 2005, 149(26):1454.","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"5","key":"143_CR17","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00129492-200209000-00026","volume":"23","author":"TS Kang","year":"2002","unstructured":"Kang TS, Vrabec JT, Giddings N, Terris DJ: Facial nerve grading systems (1985\u20132002): beyond the House-Brackmann scale. Otol Neurotol 2002, 23(5):767\u2013771.","journal-title":"Otol Neurotol"},{"key":"143_CR18","doi-asserted-by":"crossref","unstructured":"Salinas RA, Alvarez G, Ferreira J: Corticosteroids for Bell\u2019s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2004, CD001942.","DOI":"10.1002\/14651858.CD001942.pub2"},{"key":"143_CR19","doi-asserted-by":"crossref","unstructured":"Allen D, Dunn L: Aciclovir or valaciclovir for Bell\u2019s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2004, CD001869.","DOI":"10.1002\/14651858.CD001869.pub2"},{"issue":"16","key":"143_CR20","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJMoa072006","volume":"357","author":"FM Sullivan","year":"2007","unstructured":"Sullivan FM, Swan IR, Donnan PT, et al.: Early treatment with prednisolone or acyclovir in Bell\u2019s palsy. N Engl J Med 2007, 357(16):1598\u20131607.","journal-title":"N Engl J Med"},{"issue":"11","key":"143_CR21","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S1474-4422(08)70221-7","volume":"7","author":"M Engstr\u00f6m","year":"2008","unstructured":"\u2022\u2022 Engstr\u00f6m M, Berg T, Stjernquist-Desatnik A, et al.: Prednisolone and valaciclovir in Bell\u2019s palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol 2008, 7(11):993\u20131000. This study included 839 BP patients treated within 72\u00a0h of onset of symptoms in a double-blind protocol. It found that patients receiving prednisolone alone achieved a significantly shorter time to full recovery compared with those receiving combination therapy. At 6\u00a0months, full recovery was achieved in 71% (n\u2009=\u2009150) of the prednisolone\/placebo group (P\u2009<\u20090.003), 58% (n\u2009=\u2009120) of the valacyclovir\/placebo group (P\u2009<\u20090.0001), 72% (n\u2009=\u2009149) of the prednisolone\/valacyclovir group (P\u2009<\u20090.0001), and 62% (n\u2009=\u2009127) of the double-placebo group (P\u2009<\u20090.0001). Further, use of antiviral treatment did not provide any additional benefit.","journal-title":"Lancet Neurol"},{"issue":"11","key":"143_CR22","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00415-008-0008-6","volume":"255","author":"M Minnerop","year":"2008","unstructured":"Minnerop M, Herbst M, Fimmers R, et al: Bell\u2019s palsy: combined treatment of famciclovir and prednisone is superior to prednisone alone. J Neurol 2008, 255(11):1726\u20131730.","journal-title":"J Neurol"},{"issue":"3","key":"143_CR23","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/01.mao.0000265190.29969.12","volume":"28","author":"N Hato","year":"2007","unstructured":"Hato N, Yamada H, Kohno H, et al.: Valacyclovir and prednisolone treatment for Bell\u2019s palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol 2007, 28(3):408\u2013413.","journal-title":"Otol Neurotol"},{"issue":"1","key":"143_CR24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.mlg.0000248737.65607.9e","volume":"117","author":"K Kawaguchi","year":"2007","unstructured":"Kawaguchi K, Inamura H, Abe Y, et al: Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell\u2019s palsy. Laryngoscope 2007, 117(1):147\u2013156.","journal-title":"Laryngoscope"},{"issue":"3","key":"143_CR25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.amjoto.2007.05.001","volume":"29","author":"SG Yeo","year":"2008","unstructured":"Yeo SG, Lee YC, Park DC, Cha CI: Acyclovir plus steroid vs steroid alone in the treatment of Bell\u2019s palsy. Am J Otolaryngol 2008, 29(3):163\u2013166.","journal-title":"Am J Otolaryngol"},{"issue":"9","key":"143_CR26","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/jama.2009.1243","volume":"302","author":"JR Almeida de","year":"2009","unstructured":"\u2022 de Almeida JR, Al Khabori M, Guyatt GH, et al.: Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis. JAMA 2009, 302(9):985\u2013993. The authors performed a meta-analysis of 18 clinical trials totaling 2,786 patients with BP to determine the effect of corticosteroids and antiviral agents on the risk of unsatisfactory facial recovery. Corticosteroids were found to reduce the risk of an unsatisfactory recovery outcome, whereas antiviral agents were found to have no beneficial effect. The combination of corticosteroids and antiviral agents had a borderline effect in reducing the risk of an unsatisfactory recovery outcome.","journal-title":"JAMA"},{"issue":"6","key":"143_CR27","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/archoto.2009.44","volume":"135","author":"JK Goudakos","year":"2009","unstructured":"\u2022 Goudakos JK, Markou KD: Corticosteroids vs corticosteroids plus antiviral agents in the treatment of Bell palsy: a systematic review and meta-analysis. Arch Otolaryngol Head Neck Surg 2009, 135(6):558\u2013564. Five randomized controlled studies published from 1996 to 2007 totaling 738 patients were analyzed. The authors found no benefit from adding an antiviral agent to corticosteroids in increasing the recovery rate of FNP in patients with BP.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"6","key":"143_CR28","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/00129492-200311000-00022","volume":"24","author":"N Hato","year":"2003","unstructured":"Hato N, Matsumoto S, Kisaki H, et al.: Efficacy of early treatment of Bell\u2019s palsy with oral acyclovir and prednisolone. Otol Neurotol 2003, 24(6):948\u2013951.","journal-title":"Otol Neurotol"},{"issue":"16","key":"143_CR29","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMe078188","volume":"357","author":"DH Gilden","year":"2007","unstructured":"Gilden DH, Tyler KL: Bell\u2019s palsy\u2014is glucocorticoid treatment enough? N Engl J Med 2007, 357(16):1653\u20131655.","journal-title":"N Engl J Med"},{"issue":"1 Pt 1","key":"143_CR30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-124-1_Part_1-199601010-00005","volume":"124","author":"S Murakami","year":"1996","unstructured":"Murakami S, Mizobuchi M, Nakashiro Y, et al.: Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 1996, 124(1 Pt 1):27\u201330.","journal-title":"Ann Intern Med"},{"key":"143_CR31","doi-asserted-by":"crossref","first-page":"b255","DOI":"10.1136\/bmj.b255","volume":"338","author":"V Madhok","year":"2009","unstructured":"Madhok V, Falk G, Fahey T, Sullivan FM: Prescribe prednisolone alone for Bell\u2019s palsy diagnosed within 72\u00a0h of symptom onset. BMJ 2009, 338:b255.","journal-title":"BMJ"},{"issue":"2","key":"143_CR32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ncpneuro1002","volume":"5","author":"KL Tyler","year":"2009","unstructured":"Tyler KL: Prednisolone\u2014but not antiviral drugs\u2014improves outcome in patients with Bell\u2019s palsy. Nat Clin Pract Neurol 2009, 5(2):74\u201375.","journal-title":"Nat Clin Pract Neurol"},{"issue":"9645","key":"143_CR33","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(08)61515-9","volume":"372","author":"RJ Davenport","year":"2008","unstructured":"Davenport RJ, Sullivan F, Smith B, et al.: Treatment for Bell\u2019s palsy. Lancet 2008, 372(9645):1219\u20131220; author reply 1220\u20131211.","journal-title":"Lancet"},{"key":"143_CR34","doi-asserted-by":"crossref","unstructured":"Lockhart P, Daly F, Pitkethly M, et al.: Antiviral treatment for Bell\u2019s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2009, CD001869.","DOI":"10.1002\/14651858.CD001869.pub4"},{"issue":"4","key":"143_CR35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0002-9394(14)77025-4","volume":"110","author":"BR Frueh","year":"1990","unstructured":"Frueh BR, Preston RA, Musch DC: Facial nerve injury and hemifacial spasm. Am J Ophthalmol 1990, 110(4):421\u2013423.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"143_CR36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0039-6257(89)90040-4","volume":"34","author":"DR Jordan","year":"1989","unstructured":"Jordan DR, Patrinely JR, Anderson RL, Thiese SM: Essential blepharospasm and related dystonias. Surv Ophthalmol 1989, 34(2):123\u2013132.","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"143_CR37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/01658108608997319","volume":"6","author":"H Cramer","year":"1986","unstructured":"Cramer H, Otto K: Meige\u2019s syndrome: clinical findings and therapeutic results in 50 patients. Neuroophthalmology 1986, 6(1):3\u201315.","journal-title":"Neuroophthalmology"},{"issue":"7","key":"143_CR38","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/1352458508090668","volume":"14","author":"G Koutsis","year":"2008","unstructured":"Koutsis G, Kokotis P, Sarrigiannis P, et al.: Spastic paretic hemifacial contracture in multiple sclerosis: a neglected clinical and EMG entity. Mult Scler 2008, 14(7):927\u2013932.","journal-title":"Mult Scler"},{"issue":"1","key":"143_CR39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/brain\/84.1.31","volume":"84","author":"F Andermann","year":"1961","unstructured":"Andermann F, Lloydsmith DL, Gloor P, et al.: Facial myokimia in multiple sclerosis. Brain 1961, 84(1):31.","journal-title":"Brain"},{"issue":"6","key":"143_CR40","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archneur.1974.00490360001001","volume":"30","author":"RB Tenser","year":"1974","unstructured":"Tenser RB, Corbett JJ: Myokymia and facial contraction in brain stem glioma. An electromyographic study. Arch Neurol 1974, 30(6):425\u2013427.","journal-title":"Arch Neurol"},{"issue":"4","key":"143_CR41","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/archneur.1979.00500400098019","volume":"36","author":"EA Waybright","year":"1979","unstructured":"Waybright EA, Gutmann L, Chou SM: Facial myokymia. Pathological features. Arch Neurol 1979, 36(4):244\u2013245.","journal-title":"Arch Neurol"},{"issue":"1","key":"143_CR42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0022-510X(88)90175-X","volume":"84","author":"L Bettoni","year":"1988","unstructured":"Bettoni L, Bortone E, Ghizzoni P, Lechi A: Myokymia in the course of Bell\u2019s palsy. An electromyographic study. J Neurol Sci 1988, 84(1):69\u201376.","journal-title":"J Neurol Sci"},{"key":"143_CR43","first-page":"1392","volume-title":"Textbook of Clinical Neurology","author":"DE Brackmann","year":"2003","unstructured":"Brackmann DE, Fetterman BL: Cranial nerve VII. In Textbook of Clinical Neurology. edn. 3. Edited by Goetz CG. Oxford, UK: Saunders Elsevier; 2003:1392.","edition":"3"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-010-0143-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-010-0143-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-010-0143-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T18:13:39Z","timestamp":1636481619000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-010-0143-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,14]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["143"],"URL":"https:\/\/doi.org\/10.1007\/s11910-010-0143-1","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,14]]}}}